Israel Ambulatory Surgical Services Market Size and Forecast by Service Type, Facility Type, Ownership Model, and Patient Age Group: 2019-2034

Aug 2026
Format:
PDF Excel
Pages: 110+
Type: Niche Market Report
Authors: Prayag Singh (Asst. Manager)
USD 405.8 Million
Market Size 2026
USD 596.7 Million
Forecast 2034
4.94%
CAGR 2026–2034

Israel's kupot holim framework has not opened independent ASC formation at scale; instead

Find the Right Plan
4 flexible options to match your research needs.
Single Report 50% OFF $495
You Save $495 (50%)
Excel Datasheet Only $345
You Save $345 (50%)
Pack of 2 Reports $445/report
You Save $50/report (10%)
3rd Report Onwards $435/report
You Save $60/report (12%)
Annual Subscription
You Save $1,000+/year From $2,499/yr
100% Secure Checkout
SSL encrypted
24/7 Customer Support
We're here to help
Israel Ambulatory Surgical Services Market Size | 2019-2034
Healthcare and MedTech
Healthcare Services

Market Outlook

Aug 2026 Edition · Historical 2019–2025 · Forecast 2026–2034
Core
  • The Israel industry is projected to be valued at USD 405.8 Million in 2026.
  • Our projections suggest that the Israel Ambulatory Surgical Services Market will reach USD 596.7 Million by 2034, registering a CAGR of 4.94% during the forecast period.
Industry Shift: Health plan control, constrained independent facility entry
Israel's four kupot holim health plans retain procedural gatekeeping authority over same-day surgical volume, concentrating licensed outpatient surgical delivery within affiliated networks and limiting commercially independent facility formation outside those structures.

Kupot Holim Network Control: Outpatient Surgery's Structural Opening

Israel's four statutory health funds — Clalit, Maccabi, Meuhedet, and Leumit — collectively govern surgical referral pathways for the entire insured population under the National Health Insurance Law, and their concentrated purchasing authority has historically channeled elective procedures toward affiliated hospital settings rather than independent outpatient facilities. The more consequential structural condition, however, is that kupot holim contracting determines whether an ambulatory surgery center can achieve the patient volume required for financial viability, meaning independent facility operators without fund agreements face structural exclusion from the primary demand pool. As of 2026, rising surgical wait times within fund-affiliated hospitals have created measurable pressure on the kupot to diversify their contracted surgical capacity, making outpatient facilities a functionally necessary release valve rather than a discretionary alternative. The evidence points less to organic facility formation and more to fund-driven procurement shifts that may selectively open contracted access to licensed ambulatory centers in ophthalmology, orthopedics, and gastroenterology — segments where procedure standardization supports cost-efficient outpatient delivery outside hospital infrastructure.

Market Scope

Coverage
Comprehensive breakdown of market scope across key dimensions View Full Methodology
Segment Dimension
Segment Items
Service Type
Orthopedic Surgical Services Ophthalmic Surgical Services Gastrointestinal Endoscopic Services General Surgical Services ENT Surgical Services Gynecological Surgical Services Urological Surgical Services Pain Management and Interventional Services Plastic and Reconstructive Surgical Services Oral and Maxillofacial Surgical Services Other Specialty Surgical Services
Facility Type
Ambulatory Surgical Centers (Independent ASCs) Hospital Outpatient Departments (HOPDs) Office-Based Surgical Facilities (OBS)
Ownership Model
Independent Physician-Owned Hospital-Owned Corporate-Owned
Patient Age Group
Pediatric Adult Geriatric

Table of Contents

8 chapters · 24 sections
Structure
1.1 Executive Summary
1.2 Research Methodology
1.3 Scope & Definition
2.1 Industry Overview
2.2 Market Dynamics
2.2.1 Market Drivers
2.2.2 Market Restraints
2.2.3 Market Trends
2.3 Industry Analysis
2.3.1 Value Chain Analysis
2.3.2 Porter's Five Forces Analysis
2.4 Market Indicators
3.1 Israel Ambulatory Surgical Services Market Size and Forecast ($), 2019-2034
3.2 Israel Ambulatory Surgical Services Market Year-on-Year Growth (%), 2020–2034
4.1 Comparative Market Share Analysis, 2025 & 2034
4.2 Market Size & Forecast ($), 2019-2034
4.2.1 Orthopedic Surgical Services Segment Analysis and Trends
4.2.2 Ophthalmic Surgical Services Segment Analysis and Trends
4.2.3 Gastrointestinal Endoscopic Services Segment Analysis and Trends
4.2.4 General Surgical Services Segment Analysis and Trends
4.2.5 ENT Surgical Services Segment Analysis and Trends
4.2.6 Gynecological Surgical Services Segment Analysis and Trends
4.2.7 Urological Surgical Services Segment Analysis and Trends
4.2.8 Pain Management and Interventional Services Segment Analysis and Trends
4.2.9 Plastic and Reconstructive Surgical Services Segment Analysis and Trends
4.2.10 Oral and Maxillofacial Surgical Services Segment Analysis and Trends
4.2.11 Other Specialty Surgical Services Segment Analysis and Trends
4.3 Market Attractiveness Analysis
5.1 Comparative Market Share Analysis, 2025 & 2034
5.2 Market Size & Forecast ($), 2019-2034
5.2.1 Ambulatory Surgical Centers (Independent ASCs) Segment Analysis and Trends
5.2.2 Hospital Outpatient Departments (HOPDs) Segment Analysis and Trends
5.2.3 Office-Based Surgical Facilities (OBS) Segment Analysis and Trends
5.3 Market Attractiveness Analysis
6.1 Comparative Market Share Analysis, 2025 & 2034
6.2 Market Size & Forecast ($), 2019-2034
6.2.1 Independent Physician-Owned Segment Analysis and Trends
6.2.2 Hospital-Owned Segment Analysis and Trends
6.2.3 Corporate-Owned Segment Analysis and Trends
6.3 Market Attractiveness Analysis
7.1 Comparative Market Share Analysis, 2025 & 2034
7.2 Market Size & Forecast ($), 2019-2034
7.2.1 Pediatric Segment Analysis and Trends
7.2.2 Adult Segment Analysis and Trends
7.2.3 Geriatric Segment Analysis and Trends
7.3 Market Attractiveness Analysis
8.1 Market Share Analysis
8.2 Competitive Positioning Matrix
8.3 Key Winning Strategies & Impact

Paid Customization

8 options · Proposal within 48 hours
Custom

Tailor This Report to Your Exact Needs

All customization options are available on request. Our team will scope your requirements and provide a proposal within 48 hours.

Additional Country / Regional Coverage
Extend the report to include any additional country or sub-regional market not covered in the standard version.
Premium
Granular Segment-Level Analysis
Deeper breakdowns by sub-device category, patient sub-groups, or specific procedure types with volume and revenue data.
Premium
Competitor Benchmarking & Profiles
In-depth profiles of up to 10 additional companies including financials, product portfolios, and strategic initiatives.
Premium
Executive Summary Presentation Deck (PPT)
A ready-to-present PowerPoint deck summarizing key findings, charts, and strategic insights tailored to your audience.
Add-On
Custom Forecast Scenarios (Bull / Base / Bear)
Scenario-based modelling to stress-test market assumptions across optimistic, base-case, and conservative growth trajectories.
Premium
Regulatory & Compliance Deep-Dive
Comprehensive mapping of MDR/IVDR compliance, import regulations, clinical trial requirements, and approval pathway analysis for Turkey.
Add-On
Supply Chain & Distribution Mapping
End-to-end supply chain visualization including manufacturer, distributor, and end-user touchpoints with bottleneck risk identification.
Premium
Market Entry Strategy Advisory
Strategic market entry guidance including go-to-market planning, partner identification, pricing benchmarks, and competitive positioning.
Advisory
Ready to customize this report? Share your requirements and our research team will send you a detailed proposal with timelines and pricing within 48 hours.

Request a Free Sample

Delivered within 24 business hours
Free
What Your Sample Includes
  • Executive Summary & Strategic Market Overview
  • Key market sizing metrics with CAGR projections
  • Representative data tables, charts & segment breakdowns
  • Competitive landscape preview with leading player profiles
  • Methodology note and data validation framework
Delivery & Access
  • Delivered to your corporate inbox within 24 business hours
  • Available in PDF format — no login or download barrier
  • Accompanied by a dedicated research analyst introduction
  • Option to schedule a complimentary 15-minute briefing call
Trust & Compliance
  • SSL-encrypted submission — your data is transmitted securely
  • GDPR-compliant data handling — zero third-party sharing
  • Trusted by 500+ Fortune 1000 companies & government bodies
  • ISO-aligned research processes with independent data validation

No commitment required. No credit card. Delivered within 24 business hours.

SSL Secured GDPR Compliant No Spam Policy 500+ Enterprise Clients
Read